Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A13626 | 29866129 | BMC Gastroenterol | Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial. | 2018 | Details |
| A13680 | 29843959 | Trends Immunol | Liver-Microbiome Axis in Health and Disease. | 2018 | Details |
| A13686 | 29805971 | Int J Chronic Dis | Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report. | 2018 | Details |
| A13710 | 29797516 | Eur J Clin Invest | Exercising the hepatobiliary-gut axis. The impact of physical activity performance. | 2018 | Details |
| A13717 | 29793999 | Diabetes | The Transplantation of ω3 PUFA-Altered Gut Microbiota of fat-1 Mice to Wild-Type Littermates Prevents Obesity and Associated Metabolic Disorders. | 2018 | Details |
| A13728 | 29787859 | Contemp Clin Trials | Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease. | 2018 | Details |
| A13735 | 29785077 | World J Gastroenterol | Mediterranean diet and nonalcoholic fatty liver disease. | 2018 | Details |
| A13740 | 29781841 | Curr Opin Clin Nutr Metab Care | Carbohydrates and diet patterns in nonalcoholic fatty liver disease in children and adolescents. | 2018 | Details |
| A13769 | 29765460 | Arch Med Sci | The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention. | 2016 | Details |
| A13778 | 29761634 | Am J Med Genet C Semin Med Genet | Extracephalic manifestations of nonchromosomal, nonsyndromic holoprosencephaly. | 2018 | Details |
| A13802 | 29748586 | Nat Rev Gastroenterol Hepatol | The gut-liver axis and the intersection with the microbiome. | 2018 | Details |
| A13833 | 29735794 | Ann Hepatol | The Presence and Severity of Nonalcoholic Steatohepatitis Is Associated with Specific Changes in Circulating Bile Acids. | 2018 | Details |
| A13879 | 29713125 | World J Gastroenterol | Beneficial effects of naringenin in liver diseases: Molecular mechanisms. | 2018 | Details |
| A13884 | 29710519 | Biomed Pharmacother | Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. | 2018 | Details |
| A13909 | 29697548 | J Pediatr Gastroenterol Nutr | Bile Acids and the Gut Microbiome as Potential Targets for NAFLD Treatment. | 2018 | Details |
| A13912 | 29697458 | Eur J Gastroenterol Hepatol | Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease: a meta-analysis. | 2018 | Details |
| A13922 | 29690638 | Nutrients | Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity. | 2018 | Details |
| A13924 | 29688336 | Inflamm Bowel Dis | Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors. | 2018 | Details |
| A13928 | 29684468 | Pharmacol Ther | Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease. | 2018 | Details |
| A13929 | 29684027 | PLoS One | Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model. | 2018 | Details |
| A13933 | 29682571 | Biomed Res Int | The Association of Gut Microbiota with Nonalcoholic Steatohepatitis in Thais. | 2018 | Details |
| A13937 | 29680836 | Dig Dis | Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes. | 2018 | Details |
| A13944 | 29675753 | Curr Gastroenterol Rep | The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD). | 2018 | Details |
| A13948 | 29675053 | Evid Based Complement Alternat Med | The Potential Effect of Chinese Herbal Formula Hongqijiangzhi Fang in Improving NAFLD: Focusing on NLRP3 Inflammasome and Gut Microbiota. | 2018 | Details |
| A13969 | 29665135 | Hepatology | Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13976 | 29661926 | Clin Sci (Lond) | Disruptions in gut microbial-host co-metabolism and the development of metabolic disorders. | 2018 | Details |
| A13988 | 29655752 | Food Chem | Systematic evaluation of phenolic compounds and protective capacity of a new mulberry cultivar J33 against palmitic acid-induced lipotoxicity using a simulated digestion method. | 2018 | Details |
| A13994 | 29653359 | J Nutr Biochem | The role of the gut microbiota in the pathology and prevention of liver disease. | 2018 | Details |
| A14029 | 29627620 | Contemp Clin Trials | Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design. | 2018 | Details |
| A14034 | 29623674 | J Gastrointest Surg | Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. | 2018 | Details |
| A14078 | 29600696 | Minerva Gastroenterol Dietol | Helicobacter pylori in metabolic related diseases. | 2018 | Details |
| A14095 | 29590379 | J Clin Endocrinol Metab | Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes. | 2018 | Details |
| A14109 | 29577863 | Curr Clin Pharmacol | Hepatic Elimination of Drugs in Gestational Diabetes. | 2018 | Details |
| A14125 | 29572891 | Hepatology | Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. | 2018 | Details |
| A14141 | 29566909 | Best Pract Res Clin Gastroenterol | NAFLD, Helicobacter species and the intestinal microbiome. | 2017 | Details |
| A14149 | 29563854 | Mediators Inflamm | Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14180 | 29548345 | BMC Pharmacol Toxicol | A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis. | 2018 | Details |
| A14190 | 29538359 | Pediatr Res | Gut microbiota in adolescents and the association with fatty liver: the EPOCH study. | 2018 | Details |
| A14191 | 29537411 | J R Coll Physicians Edinb | Bariatric surgery as a treatment for metabolic syndrome. | 2017 | Details |
| A14192 | 29536744 | Bratisl Lek Listy | The relationship between hepatocytes and small bowel after early and short food restriction: What the results show in morphometry. | 2018 | Details |
| A14212 | 29523931 | Arch Toxicol | In utero and lactational exposure to BDE-47 promotes obesity development in mouse offspring fed a high-fat diet: impaired lipid metabolism and intestinal dysbiosis. | 2018 | Details |
| A14226 | 29515630 | Iran J Pathol | Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14241 | 29508520 | Mol Nutr Food Res | Sugary Kefir Strain Lactobacillus mali APS1 Ameliorated Hepatic Steatosis by Regulation of SIRT-1/Nrf-2 and Gut Microbiota in Rats. | 2018 | Details |
| A14255 | 29503733 | BMJ Open Gastroenterol | Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study. | 2018 | Details |
| A14264 | 29495113 | Liver Int | Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. | 2018 | Details |
| A14270 | 29491146 | J Biol Chem | Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease. | 2018 | Details |
| A14286 | 29482963 | Nutr Metab Cardiovasc Dis | Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study. | 2017 | Details |
| A14290 | 29481310 | FASEB J | Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice. | 2018 | Details |
| A14321 | 29466845 | Korean J Intern Med | Duodenal Niemann-Pick C1-like 1 expression was negatively correlated with liver X receptor expression in nonalcoholic fatty liver disease. | 2018 | Details |
| A14343 | 29456073 | Cell Metab | An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans. | 2018 | Details |
| A14372 | 29441049 | Front Microbiol | Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14400 | 29427492 | Liver Int | Future therapy for non-alcoholic fatty liver disease. | 2018 | Details |
| A14424 | 29413959 | Redox Biol | Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches. | 2018 | Details |
| A14433 | 31294396 | J Can Assoc Gastroenterol | 2017 Canadian Association of Gastroenterology Educational Needs Assessment Report. | 2018 | Details |
| A14435 | 29408694 | J Hepatol | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. | 2018 | Details |
| A14458 | 29401710 | Nutrients | Dietary Iron Supplementation Alters Hepatic Inflammation in a Rat Model of Nonalcoholic Steatohepatitis. | 2018 | Details |
| A14468 | 29399077 | Exp Ther Med | Relationship between intestinal flora and inflammatory factors in patients with nonalcoholic steatohepatitis. | 2017 | Details |
| A14473 | 29397594 | Zhonghua Nei Ke Za Zhi | [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease]. | 2018 | Details |
| A14502 | 29379536 | Arch Med Sci | Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players? | 2016 | Details |
| A14526 | 29367619 | Cell Death Dis | Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. | 2018 | Details |
| A14540 | 29362454 | Sci Rep | Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. | 2018 | Details |
| A14547 | 29359454 | J Ultrasound Med | Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14561 | 29353414 | Probiotics Antimicrob Proteins | Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats. | 2019 | Details |
| A14569 | 29350612 | Microsc Microanal | The Effects of Betaine on the Nuclear Fractal Dimension, Chromatin Texture, and Proliferative Activity in Hepatocytes in Mouse Model of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14582 | 29341349 | Pathol Int | Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease. | 2018 | Details |
| A14596 | 29333610 | Aliment Pharmacol Ther | Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. | 2018 | Details |
| A14606 | 29326657 | Front Endocrinol (Lausanne) | Early Microbes Modify Immune System Development and Metabolic Homeostasis-The "Restaurant" Hypothesis Revisited. | 2017 | Details |
| A14629 | 29316191 | Liver Transpl | Microbiota and the liver. | 2018 | Details |
| A14644 | 29311399 | Ann Hepatol | Efficacy of Probiotics and Smectite in Rats with Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14659 | 29304731 | BMC Gastroenterol | Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial. | 2018 | Details |
| A14671 | 29294263 | Postepy Biochem | [NAFLD pathogenesis in the light of recent research]. | 2019 | Details |
| A14695 | 29286303 | Nutrients | Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
| A14699 | 29285942 | Orv Hetil | [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases]. | 2017 | Details |
| A14713 | 29276215 | Exp Anim | Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis. | 2017 | Details |
| A14730 | 29268121 | J Nutr Biochem | Age-dependent alterations of glucose clearance and homeostasis are temporally separated and modulated by dietary fat. | 2017 | Details |
| A14733 | 29266812 | Mol Nutr Food Res | Tomato Powder Inhibits Hepatic Steatosis and Inflammation Potentially Through Restoring SIRT1 Activity and Adiponectin Function Independent of Carotenoid Cleavage Enzymes in Mice. | 2018 | Details |
| A14741 | 29263303 | JCI Insight | Intestinal, but not hepatic, ChREBP is required for fructose tolerance. | 2017 | Details |
| A14746 | 29259643 | Evid Based Complement Alternat Med | Dahuang Zexie Decoction Protects against High-Fat Diet-Induced NAFLD by Modulating Gut Microbiota-Mediated Toll-Like Receptor 4 Signaling Activation and Loss of Intestinal Barrier. | 2017 | Details |
| A14771 | 29247356 | J Gastroenterol | Current and future pharmacological therapies for NAFLD/NASH. | 2017 | Details |
| A14789 | 29232562 | Atherosclerosis | TM6SF2: A novel target for plasma lipid regulation. | 2017 | Details |
| A14825 | 29216833 | BMC Gastroenterol | Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis. | 2017 | Details |
| A14841 | 29209116 | World J Gastroenterol | Gastric xanthelasma and metabolic disorders: A large retrospective study among Chinese population. | 2017 | Details |
| A14865 | 29200733 | Pharmacogn Mag | Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats. | 2017 | Details |
| A14876 | 29195686 | Trends Endocrinol Metab | Role of Bile Acids in Metabolic Control. | 2017 | Details |
| A14885 | 29191128 | Biosci Biotechnol Biochem | Suppressive effect of nobiletin and epicatechin gallate on fructose uptake in human intestinal epithelial Caco-2 cells. | 2017 | Details |
| A14887 | 29190550 | J Nutr Biochem | Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling. | 2017 | Details |
| A14896 | 29187142 | BMC Gastroenterol | Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis. | 2017 | Details |
| A14897 | 29187040 | JPEN J Parenter Enteral Nutr | Parenteral Soybean Oil Induces Hepatosteatosis Despite Addition of Fish Oil in a Mouse Model of Intestinal Failure-Associated Liver Disease. | 2017 | Details |
| A14931 | 29167659 | Front Microbiol | Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota. | 2017 | Details |
| A14948 | 29160087 | Antioxid Redox Signal | Glyoxalase 1 Modulation in Obesity and Diabetes. | 2018 | Details |
| A14963 | 29154964 | J Hepatol | Lipotoxicity and the gut-liver axis in NASH pathogenesis. | 2017 | Details |
| A14973 | 29150490 | Gut | Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. | 2017 | Details |
| A14975 | 29149647 | J Nutr Biochem | Dietary fish oil differentially ameliorates high-fructose diet-induced hepatic steatosis and hyperlipidemia in mice depending on time of feeding. | 2017 | Details |
| A14981 | 29144460 | Nature | Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. | 2017 | Details |
| A14985 | 29139555 | Br J Pharmacol | Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. | 2018 | Details |
| A14996 | 29131401 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study. | 2018 | Details |
| A15017 | 29128052 | Clin Liver Dis | The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A15032 | 29122851 | Gut | Guidelines on the management of abnormal liver blood tests. | 2017 | Details |
| A15040 | 29122389 | J Hepatol | The nutritional geometry of liver disease including non-alcoholic fatty liver disease. | 2017 | Details |
| A15043 | 29120742 | Cell Host Microbe | The Human Microbiome and Obesity: Moving beyond Associations. | 2017 | Details |